Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENA: MMF vs AZA for CAN Prevention in Kidney Transplant
NCT00494741Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- May 2007
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in kidney transplant rejection (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Cumulative incidence of biopsy-proven Chronic Allograft Nephropathy at 3 years. Started May 2007; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00494741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494741.